Buscar
Enovis Corp
ENOVAñadir a la lista de seguimiento
24.290USD
-1.820-6.97%
Cierre 05/15, 16:00（ET）Cotizaciones retrasadas 15 min
1.40BCap. mercado
PérdidaP/E TTM
Más Datos de Enovis Corp Compañía
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Información de Enovis Corp
Símbolo de cotizaciónENOV
Nombre de la empresaEnovis Corp
Fecha de salida a bolsaMay 08, 2008
Director ejecutivoMcdonald (Damien)
Número de empleados7367
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 08
Dirección2711 Centerville Road
CiudadWILMINGTON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal19808
Teléfono13022529160
Sitio Webhttps://www.enovis.com/
Símbolo de cotizaciónENOV
Fecha de salida a bolsaMay 08, 2008
Director ejecutivoMcdonald (Damien)
Ejecutivos de Enovis Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
32.60K
+13.31%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
18.11K
-12.48%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
13.01K
-17.38%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
9.03K
-16.51%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
8.26K
-27.37%
Mr. A. Clayton Perfall
Mr. A. Clayton Perfall
Independent Director
Independent Director
--
--
Mr. Brady R. Shirley
Mr. Brady R. Shirley
Director
Director
--
--
Mr. Bradley J. (Brad) Tandy, J.D.
Mr. Bradley J. (Brad) Tandy, J.D.
Senior Vice President, Chief Legal Officer
Senior Vice President, Chief Legal Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
32.60K
+13.31%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
18.11K
-12.48%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
13.01K
-17.38%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
9.03K
-16.51%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Medical Technology-Prevention & Rehabilitation
1.14B
50.58%
Medical Technology-Reconstructive
1.11B
49.42%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
1.30B
57.62%
Other Foreign locations
952.72M
42.38%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Medical Technology-Prevention & Rehabilitation
1.14B
50.58%
Medical Technology-Reconstructive
1.11B
49.42%
Estadísticas de accionistas
Actualizado: jue., 14 de may
Actualizado: jue., 14 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.02%
American Century Investment Management, Inc.
9.14%
Vanguard Portfolio Management, LLC
6.62%
Vanguard Capital Management, LLC
4.43%
Dimensional Fund Advisors, L.P.
4.42%
Otro
61.37%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.02%
American Century Investment Management, Inc.
9.14%
Vanguard Portfolio Management, LLC
6.62%
Vanguard Capital Management, LLC
4.43%
Dimensional Fund Advisors, L.P.
4.42%
Otro
61.37%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
66.66%
Investment Advisor/Hedge Fund
28.44%
Hedge Fund
17.41%
Research Firm
5.91%
Individual Investor
1.53%
Bank and Trust
1.19%
Pension Fund
1.14%
Venture Capital
0.04%
Insurance Company
0.03%
Participación institucional
Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
652
68.97M
119.81%
-6.76M
2025Q4
617
68.12M
125.63%
--
2025Q3
641
68.12M
128.26%
-1.19M
2025Q2
651
69.44M
130.24%
+2.07M
2025Q1
629
67.38M
125.09%
-4.06M
2024Q4
625
63.48M
125.04%
+1.28M
2024Q3
599
62.09M
124.13%
-57.94K
2024Q2
602
61.71M
121.92%
+2.05M
2024Q1
635
59.58M
125.47%
-9.23M
2023Q4
647
58.62M
120.02%
+2.97M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
8.07M
14.1%
+110.96K
+1.39%
Dec 31, 2025
American Century Investment Management, Inc.
5.26M
9.19%
+528.25K
+11.17%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
2.78M
4.86%
-189.61K
-6.38%
Dec 31, 2025
Rubric Capital Management LP
2.45M
4.29%
-296.74K
-10.79%
Dec 31, 2025
Davenport Asset Management
2.44M
4.26%
-367.69K
-13.10%
Dec 31, 2025
State Street Investment Management (US)
2.37M
4.14%
+20.61K
+0.88%
Dec 31, 2025
Dorsey Asset Management LLC
2.28M
3.98%
-120.12K
-5.01%
Dec 31, 2025
Fidelity Management & Research Company LLC
1.93M
3.37%
+665.45K
+52.61%
Dec 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
State Street SPDR S&P Health Care Equipment ETF
1.83%
Invesco S&P SmallCap Health Care ETF
1.09%
Invesco S&P SmallCap 600 Pure Value ETF
0.45%
State Street SPDR S&P 600 Small Cap Value ETF
0.25%
iShares S&P Small-Cap 600 Value ETF
0.24%
iShares U.S. Medical Devices ETF
0.21%
Humankind US Stock ETF
0.2%
State Street SPDR S&P SmallCap 600 ESG ETF
0.18%
Avantis US Small Cap Equity ETF
0.18%
Invesco S&P SmallCap 600 Revenue ETF
0.16%
Ver más
State Street SPDR S&P Health Care Equipment ETF
Proporción1.83%
Invesco S&P SmallCap Health Care ETF
Proporción1.09%
Invesco S&P SmallCap 600 Pure Value ETF
Proporción0.45%
State Street SPDR S&P 600 Small Cap Value ETF
Proporción0.25%
iShares S&P Small-Cap 600 Value ETF
Proporción0.24%
iShares U.S. Medical Devices ETF
Proporción0.21%
Humankind US Stock ETF
Proporción0.2%
State Street SPDR S&P SmallCap 600 ESG ETF
Proporción0.18%
Avantis US Small Cap Equity ETF
Proporción0.18%
Invesco S&P SmallCap 600 Revenue ETF
Proporción0.16%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Fecha
Fecha ex-dividendo
Tipo
Relación
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
